A Breakthrough Treatment for Ulcerative Colitis


4/18/2017  Pharmaceutical Industry Executive Brian W. Andersen Named Chief Business Officer

MIAMI LAKES, FL – April 18, 2017 — Asana Medical, Inc., (“Asana,” the “Company”), a regenerative medicine company that is […]

10/17/2016  IBD NEWS DAILY: Asana Reports Positive Preclinical Data of Treatment for Ulcerative Colitis

Asana Medical has announced positive data from a preclinical study using an innovative liquid treatment called Extracellular Matrix Hydrogel (ECMH)

10/4/2016  Asana Medical Inc.’s Preclinical Study Indicates Promising Solution to Treat Ulcerative Colitis

Company’s Patented Drug-Free, Non-Surgical Therapy Promotes Tissue Regeneration MIAMI LAKES, FL – October 4th, 2016 – Asana Medical, Inc., (“Asana,” […]

More News →

Asana Medical Inc.

Asana Medical Inc. is focused on providing physicians with the first-in-class non-pharmacological, non-surgical treatment option for patients suffering from gastrointestinal (GI) diseases, including Ulcerative Colitis, Crohn’s Disease, and Rectal Mucositis. Asana’s device, derived from Extracellular Matrix, will set into motion a paradigm shift in the treatment of Inflammatory Bowel Disease (IBD) and other diseases from symptom-based, anti-inflammatory therapies to providing a protective coating to promote tissue healing.

We are a GI-oriented company of highly motivated innovators, doctors, scientists, engineers, entrepreneurs, and professionals that identified an opportunity to apply existing Tissue Engineering Technology in a novel application. This will spark a change in the treatment of IBD and other GI diseases.

Facebook Twitter LinkedIn
Asana Medical Inc.
6135 NW 167 Street, Suite E15
Miami Lakes, FL 33015
tel: (844) 432-7262